Ruane Cunniff's ELV Position Overview
Ruane Cunniff (via Ruane, Cunniff & Goldfarb L.P.) currently holds 1.4M shares of Elevance Health, Inc. (ELV) worth $467.97 M, representing 7.75% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ruane Cunniff has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 672.2K shares. Largest reduction occurred in Q2 2022, reducing 743.4K shares.
Analysis based on 13F filings available since 2013 Q2
Ruane Cunniff's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Ruane Cunniff
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2021 | +1.17 M | New Buy | 1.17 M | $358.95 |
| Q2 2021 | +672,156 | Add 57.36% | 1.84 M | $381.80 |
| Q3 2021 | -22,588 | Reduce 1.22% | 1.82 M | $372.80 |
| Q4 2021 | -51,373 | Reduce 2.82% | 1.77 M | $463.54 |
| Q1 2022 | -12,612 | Reduce 0.71% | 1.76 M | $491.22 |
| Q2 2022 | -743,441 | Reduce 42.30% | 1.01 M | $482.58 |
| Q3 2022 | -26,130 | Reduce 2.58% | 987,857 | $454.24 |
| Q4 2022 | -161,334 | Reduce 16.33% | 826,523 | $512.97 |
| Q1 2023 | -19,399 | Reduce 2.35% | 807,124 | $459.81 |
| Q2 2023 | +241,524 | Add 29.92% | 1.05 M | $444.29 |
| Q3 2023 | +101,573 | Add 9.69% | 1.15 M | $435.42 |
| Q4 2023 | -28,578 | Reduce 2.48% | 1.12 M | $471.56 |
| Q1 2024 | -46,958 | Reduce 4.19% | 1.07 M | $518.54 |
| Q2 2024 | -50,614 | Reduce 4.71% | 1.02 M | $541.86 |
| Q3 2024 | -19,538 | Reduce 1.91% | 1 M | $520.00 |
| Q4 2024 | +139,420 | Add 13.88% | 1.14 M | $368.90 |
| Q1 2025 | -21,033 | Reduce 1.84% | 1.12 M | $434.96 |
| Q2 2025 | -27,265 | Reduce 2.43% | 1.1 M | $388.96 |
| Q3 2025 | +352,628 | Add 32.18% | 1.45 M | $323.12 |
Ruane Cunniff's Elevance Health Investment FAQs
Ruane Cunniff first purchased Elevance Health, Inc. (ELV) in Q1 2021, acquiring 1,171,845 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ruane Cunniff has held Elevance Health, Inc. (ELV) for 19 quarters since Q1 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ruane Cunniff's largest addition to Elevance Health, Inc. (ELV) was in Q1 2021, adding 1,171,845 shares worth $420.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ruane Cunniff's firm, Ruane, Cunniff & Goldfarb L.P., owns 1,448,283 shares of Elevance Health, Inc. (ELV), valued at approximately $467.97 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 7.75% of Ruane Cunniff's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ruane Cunniff's peak holding in Elevance Health, Inc. (ELV) was 1,844,001 shares, as reported at the end of Q2 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.